Lantern Pharma Inc. — Form 8-K
Filed September 23, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K filed 2026-09-23 by Lantern Pharma Inc. containing Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing includes 27 documents: the 8-K form, one exhibit (EX-99.1), 15 graphics, and XBRL data files. The substantive disclosure text is not provided in this document index; only file metadata is visible.
Why this rating
Filing structure and metadata only; no material facts disclosed. Cannot assess business impact without substance of Item 7.01 disclosure.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from September 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.